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The pks genomic island ofEscherichia coli encodes polyketide
(PK) and nonribosomal peptide (NRP) synthases that allow
assembly of a putative hybrid PK-NRP compound named coli-
bactin that induces DNA double-strand breaks in eukaryotic
cells. The pks-encoded machinery harbors an atypical essential
protein, ClbP. ClbP crystal structure and mutagenesis experi-
ments revealed a serine-active site and original structural fea-
tures compatible with peptidase activity, which was detected by
biochemical assays. Ten ClbP homologs were identified in silico
inNRP genomic islands of closely and distantly related bacterial
species. All tested ClbP homologs were able to complement a
clbP-deficient E. coli mutant. ClbP is therefore a prototype
of a new subfamily of extracytoplasmic peptidases probably
involved in thematuration ofNRP compounds. Such peptidases
will be powerful tools for the manipulation of NRP biosynthetic
pathways.
Polyketide (PK),3 nonribosomal peptide (NRP), and hybrid
NRP-PK natural products are very interesting compounds in
drug development strategies (1). Their biosynthesis occurs on
multimodular enzymatic assembly lines called megasynthases
(2). The conformations that establish biological activity are
attained by tailoring and editing enzymes such as acylases, alky-
lases, glycosylases, and oxidoreductases during chain growth
and after thioesterase-mediated release. The dedicated tailor-
ing enzymes are encoded by genes clustered with the assembly
line genes for coordinated regulation.
Recently, Nougayre`de et al. (3, 4) identified in Escherichia
coli strains and other Enterobacteriaceae a large (54 kb)
genomic island named pks, which encodes a typical cluster of
NRP synthases (NRPS), PK synthases (PKS), and hybrid NRPS/
PKS. The pks island was detected in E. coli strains involved in
extraintestinal infections such as urinary tract infection and
septicemia but also in commensal strains from healthy people
(3, 5, 6). The genetic and functional analyses of the pks island
indicate that it encodes for synthesis of a PK-NRP hybrid com-
pound, named colibactin. E. coli strains expressing this gene
cluster cause DNA double-strand breaks in human eukaryotic
cells during infection (3). ThisDNAdamage induces phosphor-
ylation of theH2AXhistones (H2AX) and activates the ATM-
Chk2 signaling pathway that leads to transient G2/M cell cycle
arrest and cell swelling (megalocytosis). Exposed cells exhibit
signs of incomplete DNA repair, which leads to chromosomal
instability, an increase in genemutation frequency and anchor-
age-independent colony formation, demonstrating the muta-
genic and transforming potentials of colibactin (7).
In addition to eight NRP and PK megasynthases, the pks
island encodes nine accessory, tailoring and editing enzymes
(3). Eight of these proteins, including the protein ClbP, are
required to induce DNA damage in infected cells. No protein
similar to ClbP has been reported so far as an accessory or
tailoring enzyme. Here, we determined the crystal structure of
the ClbP major domain, its biochemical activity, and we char-
acterized distant ClbP homologous proteins that form a new
subgroup of serine-reactive peptidases associated with NRP
assembly lines.
EXPERIMENTAL PROCEDURES
Strains, Plasmids, and Media—The strains and plasmids
used in this study are listed in supplemental Tables 1 and 2,
respectively. E. coli strains were routinely grown at 37 °C in
lysogeny broth (LB) or on LB agar plates. Ampicillin (100
g/ml), kanamycin (50g/ml), chloramphenicol (25g/ml), or
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tetracycline (200 ng/ml) were added as required to themedium.
Non-E. coli strains were grown as recommended by the Deut-
sche Sammlung von Mikroorganismen und Zellkulturen or
Collection de l’Institut Pasteur collections or by the givers.
DNA Cloning for ClbP Investigations—The DNA sequences
of clbP were amplified from the genome of E. coli strain
IHE3034 (3). TheDNA fragments encoding the entire ClbP and
the catalytic domain of ClbP designated ClbPpep were ampli-
fied by PCR using primer pairs clbPMK-F and clbPBN-R, and
clbP-NdeI2-F and clbP-NotI2-R (supplemental Table 3),
respectively. The PCR reactions for cloning experiments were
performed using the High Fidelity Platinum Taq polymerase
or the ExpandHigh Fidelity PCR System according to theman-
ufacturer’s instructions (Invitrogen). The amplified fragments
were purified, double-digested by MfeI/BamHI for cloning at
the EcoRI/BamHI sites of pASK-IBA33plus to obtain ClbP-
RGS6His (ClbP  C-terminal in-frame RGS6His tag), or dou-
ble-digested by and cloned at the NdeI/NotI sites of pET9am to
obtain pClbPpep (ClbP catalytic domain). In other experi-
ments, ClbP-6His was subcloned from pMB702 (3) into pBRSK
vector (8) to obtain pOB901. The constructions were checked
by double-stranded DNA sequencing (Genome Express). Plas-
mids were subsequently electroporated into competent E. coli
strains: p33ClbP and pOB901 into DH10B/pBACpksclbP
strain for HeLa cellular challenges, and pClbPpep into
BL21(DE3) strain for ClbPpep and derivative overexpression
(original strains are listed in supplemental Table 1).
Site-directed Mutagenesis—The site-directed mutagenesis
experiments were performed using the Quik-ChangeTM site-
directed mutagenesis kit according to the manufacturer’s
instructions (Stratagene). The substitutions E159K, S188A,
H257A, G328S, F316R/G328S, N331A, and C337A were indi-
vidually introduced into ClbP-RGS6His cloned into the
p33ClbP plasmid and the substitution Y186E was introduced
into ClbPpep cloned into the pClbPpep plasmid. In other
experiments, ClbP-6His S95A, K98T, and Y186Gmutants were
generated by “reverse PCR” using pOB901 as template. Reverse
PCR products were purified, ligated and transformed into
DH5. Successful mutations were confirmed by double DNA
sequencing and the final constructs were used to transform
E. coli DH10B/pBACpksclbP for p33clbP and pOB901 deriv-
ative vectors, or E. coli BL21(DE3) for pClbPpep derivative vec-
tor. The mutagenic primers are listed in supplemental Table 4.
ClbPpep and ClbPpepY186E Production and Purification—
The pClbPpep plasmid encodes the peptidase domain of ClbP
without the first 102 nucleotides and the last 390 nucleotides of
the clbP gene. These sequences encode the signal peptide
and three putative anchor hydrophobic transmembrane helices
thatwere removed to facilitate cytoplasmic expression and pro-
tein purification. The E. coli BL21(DE3) transformed with
pClbPpep plasmid was cultured in Terrific broth medium sup-
plemented with 50 g/ml kanamycin, 0.4 M D-sorbitol, and 2.5
mM-betaine. The cell culture was grown at 37 °Cwith shaking
to an A600 nm  0.7. Overexpression of the clbPpep-encoding
gene was induced with 0.2 mM isopropyl -D-thiogalactopyra-
noside overnight at 25 °C with shaking. Cells were harvested by
centrifugation (10,000  g for 10 min at 4 °C), resuspended in
20mMTris-HCl buffer (pH9.0) (4ml/g of pellet). After addition
of 5 g of lysozyme (2 h at 4 °C), cells were disrupted by ultra-
sonic treatment (four times for 30 s, each time at 20 watts). The
extract was clarified by centrifugation at 14,000 g for 60 min
at 4 °C. After addition of 2 mg of DNase I (15 min at room
temperature; Roche), the supernatant (10,000 g for 60 min at
4 °C)was dialyzed overnight against 20mMTris-HCl buffer (pH
9.0) and filtrated (0.22 m filter; Millex-GS, Millipore, Carrigt-
wohill, Ireland). Purification was carried out by ion-exchange
chromatography onto a HiTrapTM Q SepharoseTM High Per-
formance column (10 ml; Amersham Biosciences) equilibrated
with 20 mM Tris-HCl (pH 7.0) and eluted with a linear NaCl
gradient (0 to 500 mM). The ClbPpep-containing elution peak
was then purified by gel filtration chromatography onto a
SuperoseTM 12 column (3.2 30 cm; Amersham Biosciences),
which had been equilibrated and eluted with 100 mMNaCl and
5 mM phosphate buffer (pH 8.0). The ClbPpep-containing elu-
tion peak was extensively dialyzed against 50 mM NaCl, 5 mM
phosphate buffer (pH 8.0), concentrated by ultrafiltration to 10
mg/ml for crystallization. The enzyme was 95% homogene-
ous as determined by Coomassie Blue staining after SDS-
PAGE. The N-terminal sequencing of the isolated protein was
achieved by sequential Edman reaction (Plate-forme de Pro-
te´omique Analytique et Fonctionnelle, Institut National de
Recherche Agronomique, Nouzilly, France). Production and
purification of ClbPpepY186E were performed in the same way
using the plasmid pClbPpepY186E.
Crystallization and Structure Determination—ClbP crystals
were grown in hanging drops over a well solution of 0.8 M
monosodium dipotassium phosphate buffer (pH 7.0). Crystals
reached a size of 40 m  40 m  70 m within 4 weeks.
Before data collection, crystals were immersed for 30 s in a
cryoprotectant solution (20% sucrose, 1.0 Mmonosodiumdipo-
tassium phosphate, pH 7.0) and were flash-cooled in liquid
nitrogen.Datawere collected using aQ315rADSC-CCDdetec-
tor on ESRF beamline 14-4 at the European Synchrotron Radi-
ation Facility (Grenoble, France). Reflexions were indexed,
integrated, and scaled using the CCP4 package (9). The initial
model was obtained by molecular replacement with the pro-
gramPHASER (10) and the x-ray structures (ProteinData Bank
codes 1E15, 1RGY, and 1FR1) as a search model. The structure
was automatically and manually refined with REFMAC5 and
COOT programs, respectively (11, 12). Cross-validation was
used throughout, and 5% of the data were used for the Rfree
calculation. The stereochemical quality of themodelswasmon-
itored with the PROCHECK program (13). Ramachandran
plots were calculated by RAMPAGE (14). Processing and crys-
tallographic refinement statistics for ClbPpep crystal structure
are listed in supplemental Table 5.
Enzyme Assays—D-Aminopeptidase activity was detected by
monitoring the formation of p-nitroaniline from Gly-, D-Ala-,
L-Ala-, and L-Ala-L-Ala-p-nitroanilide (Bachem) at 405 nm in a
100mMTris, 75mMNaCl buffer (pH 7.5) at 25 °C.-Lactamase
activity was tested by monitoring the hydrolysis of nitrocefin
(Calbiochem) at 482 nm in a 100 mM Tris, 75 mM NaCl buffer
(pH 7.5) at 25 °C.
Mass Spectrometry—ClbPpep (20M)was incubated at 20 °C
for 24 h in a 100 mM Tris, 75 mMNaCl buffer (pH 7.5) alone, or
with 20 mM imipenem (Sigma), in a 1-ml final volume. The
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reaction mixtures were desalted by dialysis against a 5 mM
ammonium bicarbonate buffer, before analysis by MALDI-
TOF mass spectrometry. The sample was spotted onto the
stainless steel target (Applied Biosystems) and an equal volume
of matrix solution (14 mg/ml sinapinic acid in 50% acetonitrile
in water containing 0.1% trifluoroacetic acid) was deposited
into the sample drop.MALDI-TOFmass spectrawere acquired
on a Voyager DE-PRO mass spectrometer (Applied Biosys-
tems) in a linear positive mode, using an accelerating voltage of
25 kV, a grid voltage of 93%, a pulse delay extraction of 700 ns,
in the 15,000–50,000 m/z mass range. Calibration was per-
formed in a close external mode using a protein calibration
mixture (LaserBio Labs).
Western Blot Experiments—Protein samples (20–25 g for
each sample) were resolved by SDS-PAGE separation electro-
phoresis on 12.5% polyacrylamide gels, immobilized onto
PVDFmembranes, and analyzed by immunoblot using the ECL
blotting system (Amersham Biosciences), and monoclonal
anti-RGS6His or anti-5His antisera (Qiagen, France), accord-
ing to the manufacturer’s instructions.
DNA Cloning of ClbP Homolog-encoding Genes—The DNA
fragments encoding ClbP homologs (the N-terminal signal
sequence, the large extracytoplasmic and catalytic domain, and
the three C-terminal transmembrane helices, without the puta-
tive “half-size” ABC-type exporter domain if present) of
Hahella chejuensisKCTC2396T (locus tagHCH_03446),Bacil-
lus cereus UW85 (locus tag zmaM), Bacillus weihenstephanen-
sis KBAB4 (locus tag BcerKBAB4_1783), Clostridium cellulo-
lyticum H10 (locus tag Ccel_2389), Bacillus mycoides DSM
2048 (locus tag bmyco0001_51990), Bacillus pseudomycoides
DSM 12442 (locus tag bpmyx0001_2150), and Staphylococcus
aureusMu50 (locus tag SAV2441) were amplified by PCR using
primers listed in supplemental Table 3, purified, double-di-
gested by MfeI or EcoRI (according to primer name) and
BamHI orXhoI for cloning at the EcoRI/BamHI orXhoI sites of
pASK-IBA33plus (C-terminal in-frame with RGS6His tag)
resulting in plasmids listed in supplemental Table 2. The con-
structions were checked by double-stranded DNA sequencing
(Genome Express). Plasmids were electroporated into compe-
tent DH10B/pBACpksclbP.
Eukaryotic Cell Culture, Bacterial Infections, H2AX Stain-
ing, and Cell Cycle Analysis—Cell assays were performed as
described previously with minor modifications (3). For bacte-
rial infections, overnight LB-ampicillin cultures of bacteria
were diluted in interaction medium (DMEM, 5% FCS, 25 mM
HEPES, 100 g/ml ampicillin). For experiments with ClbP
homologs, tetracycline was added to overnight cultures and
interacting medium to induce their expression. Approximately
50% confluent HeLa cell cultures (ATCC CCL2) were then
infected with amultiplicity of infection (number of bacteria per
eukaryotic cell) of 100. Cells were washed 4 h after inoculation
and incubated in DMEM 10% FCS, 200g/ml gentamicin until
analysis. Cell morphology was examined by Giemsa staining at
72 h after infection. For H2AX staining, cells were fixed at 4 or
20 h after infection in 4% formaldehyde and incubated with
anti-phospho-H2AX (Ser-139) antibodies (JBW301, Upstate)
followed by FITC- or rhodamine-conjugated secondary anti-
bodies. DNAwas stainedwithDAPI or TO-PRO-3 (Invitrogen)
and images were acquired with a Zeiss LSM 510Meta or Olym-
pus IX70 laser scanning confocal microscope, and the confocal
aperturewas set to achieve a z optical thickness of0.5m. For
cell cycle analysis, cellular suspensions were fixed and permea-
bilized with 70% ethanol at 48 h after infection and then treated
with 50 g/ml propidium iodide and 250 g/ml RNase. DNA
content data were acquiredwith an SLR II or FACSCalibur flow
cytometer (Becton Dickinson) and analyzed with FlowJo soft-
ware (Tree Star).
Bioinformatics—The search for ClbP homologous proteins
and analysis of their topology were performed using BLAST
(15) and the InterProScan server. Multiple sequence alignment
of peptidase domains and phylogenic tree were performed
using COBALT and TOPALi software (version 2.5) (16, 17).
Analysis of the genetic context of ClbP- and FmtA-like-encod-
ing genes (more or less 30 kb of both sides of the genes) was
performed manually from the NCBI genome database. The
analysis of PK and NRP megasynthase domains and their sub-
strate specificity was performed using the SEARCHNRPS-PKS
program.
RESULTS
In Silico Analysis of ClbP—The clbP open reading frame was
predicted to encode a 504-amino acid periplasmic inner mem-
brane-anchored protein comprising three parts: (i) a C-termi-
nal domain of three transmembrane helices (residues 390–412,
433–455, and 465–485), (ii) an N-terminal signal sequence
(ALA-30-QE-31), and (iii) a large periplasmic domain (posi-
tions 31–375). According to primary structure comparisons,
the last domain exhibits the two conserved motifs (95SMS98K
versus SxxK and 186YAS versus YxN) that characterize the cat-
alytic center of the MEROPS S12 enzyme family (18) and is
therefore designated hereafter as ClbPpep. The S12 family is a
heterogeneous group of active site serine enzymes, of which the
substrates are peptides or closely related compounds such as
-lactams. The activity and biological function of a few of these
enzymes have been described, such as class C -lactamases,
R61 D-Ala-D-Ala carboxypeptidase B, DmpB aminopeptidase,
Pab87 peptidase, D-amino acid amidase, and EstB esterase (19–
24). However, the activity and the function of numerous
enzymes of the MEROPS S12 family remain unassigned, nota-
bly the FmtA-like proteins (25), which have been previously
reported to be related to ClbP (3).
Structure Determination of ClbP Peptidase Domain—To
investigate the function and activity of ClbP, the structure of
the ClbPpep domain was determined by x-ray diffraction. The
structurewas refined against diffraction data extending to 2.4Å
resolution. The electron density map (supplemental Fig. 1)
showed well defined density throughout most of the structure,
with the exception of the six N-terminal residues. Diffuse den-
sity indicated disorder in the loop harboring residues 241–249.
The stereochemical parameters of the model were satisfactory
(supplemental Table 5); a Ramachandran plot showed no resi-
dues in disallowed regions of / space. The final model
included three ClbPpep monomers and 277 water molecules.
The three-dimensional structure of ClbPpep consists of two
structural regions, all- and / (Fig. 1A). The / region is
formed by residues 41–112 and 206–375, and the domain folds
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as a seven-stranded anti-parallel -sheet (b1, b2, b9, b10, b11,
b12, and b13)with six-helices and three-strands (b3, b4, and
b7) packed on both faces of the sheet. The all-helical region
(residues 113–205) contains four helices and loops. The con-
served motifs 95SMSK and 186YAS, which correspond to S12
enzyme active site, are located in a large groove, between the
two structural domains near the N terminus of the first helix of
the all- domain.
As expected, the most pronounced homology using the
DALI program was obtained with the structure of S12 family
members (supplemental Table 6), especially E. coli AmpC
-lactamase and Pab87 peptidase (26). Although their overall
fold was clearly similar, there are significant differences affect-
ing the accessibility of the active site from the surrounding sol-
vent. In comparison with AmpC -lactamases, the upper part
of the catalytic pocket was largely open, because of the absence
of two helices (h9 and h10) (Fig. 1, A and E), as observed in
Pab87 peptidase and R61 carboxypeptidase (21, 27). Moreover,
the remaining structural element of ClbP in this area, the loop
between residues 295–315, b9, and b10 strands (residues 310 to
311 and 316–318, respectively), moved away from the catalytic
pocket, resulting in a widening of the catalytic groove, which
was unusually larger than the known structures of S12 enzymes.
In the bottom part of the catalytic pocket, ClbPpep and Pab87
peptidases harbored the additional helix h4 (residues 166–
170) in contrast with AmpC enzymes (Fig. 1, A and E). This
helix slightly obstructed accessibility to the ClbPpep catalytic
pocket. However, the entrance of the binding site was more
FIGURE 1. Overall structure of ClbPpep, AmpC -lactamase (Protein Data Bank code 1KVL) and Pab87 peptidase (Protein Data Bank code 2QMI).
A, superimposition of ClbPpep (green), AmpC (gray) (19), and Pab87 peptidase (yellow) (21) presented as ribbons. The loops including helixes h9 and h10 are
circled in red. Helixes h4 are circled in blue. The active serine is indicated by a red star. ClbPpep (B), AmpC (C), and Pab87 peptidase (D) surfaces. The catalytic
grooves are circled in pink, and the active serine surfaces are shown in red. E, sequence alignmentswith secondary structures of ClbPpepwith Pab87 peptidase
and E. coli AmpC -lactamase. The alignment was performed based on the superposed structures. The motifs SxxK and YxN, which defined the MEROPS S12
peptidase family, are indicated by a diamond.
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open inClbPpep than in S12 peptidases, which harbor one, two,
or several bulky helices in this area. Of note, between Cys-337
and Cys-367, ClbP harbored a disulfide bond, which links b12
strand (residues 335–341) with the C-terminal helix h11. To
our knowledge, this disulfide bond is not observed in other
known structures of S12 enzymes. Overall, the ClbPpep struc-
ture was closely similar to that of S12 peptidases. However,
ClbPpep had noticeable conformational differences in the
active site, especially in the two extremities of the catalytic
groove, which was unusually large (Fig. 1, B–D). This atypical
shape suggests an adaptation of ClbP catalytic pocket to a spe-
cific substrate.
Catalytic Residues and Implications for Catalysis—Striking
structural similarities were observed between the active site of
ClbPpep, class C -lactamases, and other S12 enzymes such as
Pab87 peptidase (21, 28, 29), in particular, for the motif 95SxxK
and theTyr-186 residue. The positioning of this last residue and
the presence of His-327 make the ClbPpep active site very sim-
ilar to that of Pab87 peptidase (Fig. 2, A and B). In addition, the
location and geometry of the residues Ser-95, Lys-98, and Tyr-
186 suggest a direct role in the catalytic mechanism mediated
by ClbP (31, 32).
To confirm the importance of these residues in ClbP, substi-
tutions S95A, K98T, and Y186G were introduced by site-di-
rected mutagenesis residues into His-tagged ClbP. The result-
ing mutants were assessed for their ability to restore the
cytopathic activity of the pks-positive E. coli clbP isogenic
mutant. Infected HeLa cells were analyzed for megalocytosis,
G2/M cell cycle arrest, and phosphorylation of histone H2AX
(3). None of these mutants were able to restore the cytopathic
activity of the pks-positive E. coliclbP isogenicmutant in con-
trast with the wild-type ClbP protein (Fig. 2, C and D). These
results confirm the identification of the active site and the
importance of ClbP main domain for the functionality of pks
island. They also suggest that these enzymes and other S12
serine active-site enzymes share a catalytic mechanism.
Residues Surrounding Catalytic Residues and Substrate
Binding—The motif YxN, which is observed in most S12
enzymes, was replaced by the 186YAS motif in ClbP (Fig. 2B).
Ser-188 in ClbP was hydrogen bonded to the Lys-98 residue of
motif SxxK (Fig. 2A). In class C -lactamases, the structural
analog of Ser-188 is Asn-152, which interacts with both the
substrates and Lys of the motif SxxK (19). His-257 of ClbP,
which points at the vicinity of Ser-188, may also play a role in
FIGURE 2. Key residues in the ClbP active site. A, residues of ClbP located in close vicinity of the binding site. Hydrogen bonds are indicated by pink dashed
lines, and the water molecules are indicated by W. Carbon atoms are colored green, oxygen atoms are colored red, and nitrogen atoms are colored blue.
B, overlay of penicillin-recognizingmotifs of ClbP, Pab87 peptidase, and AmpC -lactamase. Carbon atoms of ClbP, Pab87 peptidase, and AmpC -lactamase
are in green, yellow, and gray, respectively. The motifs SxxK, Yx(N/S/T), and (K/H)(S/T/G)G are numbered in red, blue, and green, respectively, and residue
numbering is according to the ClbP sequence. C andD, phenotypic analysis of pks island activity in E. coliDH10B/pBACpks deleted or not for the clbP gene and
trans-complementedwith ClbPWT protein or the S95A, K98T, or Y186G active site ClbPmutants. HeLa cells were infected 4 hwith 100 E. coli per cell, and then
the cells were washed and incubated with gentamicin for 4–72 h. C, anti-5His Western blot analysis of the expression of His-tagged WT and active site ClbP
mutants in E. coli DH10B/pBACpksclbP after infection. D, host histone H2AX Ser-139 phosphorylation (H2AX) indicative of DNA double-strand breaks was
assayed by confocal immunofluorescence 4 h after infection. DNA and H2AX are pseudocolored in blue and red, respectively (bars, 20 m). Cell swelling
(megalocytosis) was observed following Giemsa staining 72 h after infection (bars, 50 m). G2 cell cycle arrest following DNA damage was assessed by flow
cytometric DNA content analysis, 48 h after infection.
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substrate binding. Opposite the 186YAS motif, the catalytic
pocket of ClbP exhibits the HGGmotif. The alignment of ClbP
with class C -lactamases revealed that HGG motif is a struc-
tural analog of KTGbox (Fig. 2B), which is involved in substrate
binding because of Lys and Thr (29). In -lactamases, Lys can
be replaced by the closely related residues His or Arg, and Thr
may be replaced by Ser. A positively charged side chain fol-
lowed by one bearing a hydroxyl group has therefore been sug-
gested to be universally conserved. The second residue in ClbP
motif is an atypical residue Gly-328 instead of the canonical
residues Ser or Thr, which are usually directly involved in sub-
strate recognition via a hydrogen bond (29). However, in the
vicinity of Gly-328 (Figs. 1E and 2A), positions 330 and 331 of
ClbP harbor the unusual residues Gln and Asn respectively,
which point toward the catalytic pocket and may establish
hydrogen bonds with substrates.
The residues Glu-159 and Phe-316 of ClbPpep are structural
analogs of positions involved in the binding of the N-terminal
and C-terminal parts of peptides in S12 amino- and carboxy-
peptidases, respectively. These positions determine the car-
boxypeptidase or aminopeptidase activity of S12 peptidases
(30). Previous studies suggest that the residues Glu-159 and
Phe-316 of ClbP (Fig. 2A) should favor aminopeptidase activity
because the negatively charged residueGlu-159may accommo-
date the positively chargedN-terminal part of peptides, and the
absence of positively charged residue in position 316 may alter
the accommodation of the negatively charged C-terminal part
of peptides.
Overall, the six positions 159, 188, 257, 316, 328, and 331 can
therefore participate in substrate binding in ClbP because the
site chain of these residues pointed toward the catalytic pocket
(Fig. 2A). The hydrogen bond donors Ser-188 and His-257 of
ClbP-His were replaced by Ala, which is not able to accept or
give hydrogen bonds. The substitutions E159K and F316Rwere
introduced into ClbP-His to modify the charges in the critical
areas of the catalytic pocket. We introduced the substitution
G328S to check whether a small residue is required in the
second position of the motif HGG to accommodate ClbP sub-
strate. The substitution C337A was also introduced into ClbP-
His to check the importance of the disulfide bond Cys-337–
Cys-367 for stability or folding. No substitution altered the
trans-complementing activity of these ClbP variants in the pks-
positive E. coli clbP isogenic mutant. ClbP activity may have
been only weakly modified by these substitutions. Unfortu-
nately, efficient biochemical tests are not yet available to mon-
itor ClbP activity. However, cellular tests are a good represen-
tation of the physiological context, and the results are evidence
of substrate tolerance of ClbP.
ClbP Is a Peptidase and NRP-recognizing Protein—As ClbP
presents a S12 enzyme scaffold and catalytic residue position-
ing close to Pab87 peptidase, peptidase activitywas investigated
using the reporters Gly-, D-Ala-, L-Ala-, and L-Ala-L-Ala-p-ni-
troanilides. The catalytic efficiency kcat/Km of ClbPpep against
these substrates were 0.005, 0.018, 0.020, and 0.040 M1
min1, respectively. This peptidase activity is weak in compar-
ison with that of enzymes really adapted to these substrates
such as S12 aminopeptidases (30). However, in a ClbPpep
mutant harboring the substitutionY186E, therewas no activity,
which confirms the involvement of the ClbP binding site in
peptidase activity.
Imipenem is a NRP-type compound belonging to the chem-
ical group of -lactams, which efficiently bind members of the
S12 enzyme family, such as carboxypeptidase andAmpC -lac-
tamases (33, 34). ClbPpep incubated with imipenem was ana-
lyzed by mass spectrometry (supplemental Fig. 2). Imipenem
induced amass shift consistentwith the formation of imipenem
acyl-enzyme complex of ClbPpep, as observed for -lactam-
binding proteins (35). Despite a high concentration of imi-
penem (ratio imipenem/ClbPpep  1/1000), part of ClbPpep
exhibited a mass corresponding to the native protein. The
results show that ClbP is able to bind NRP-type compounds,
has a moderate -lactam-recognizing activity, and is devoid of
significant -lactamase activity. The kcat value (0.001 M1
s1) was 1 million-fold lower than typical values of AmpC
enzymes (36). Consequently ClbP, in contrast to AmpC, was
not able to increase the resistance level of E. coli to -lactam
antibiotics.
Identification of ClbP Homologs across Prokaryotic Lineages—
We therefore screened public protein and genomic databases
to identify proteins homologous to ClbP peptidase domain. 77
homologs were obtained including the protein ZmaM, which
may be involved in the synthesis of the PK-NRP antibiotic zwit-
termicin A (ZmA) (37). These proteins only shared 29.3%
(ZP_04059476.1) to 42.7% (ZP_04215168.1) identity and all
belonged to the MEROPS S12 enzyme family. The amino acid
sequences and the predicted topology of both ClbP and the
homologs were compared with those of representative mem-
bers of the S12 family that have been assigned to a biological
function and/or a biochemical activity. The resulting phyloge-
netic tree and the topologies revealed that the proteins clus-
tered in three major branches supported by high bootstrap val-
ues (64%) (supplemental Fig. 3). One branch harbored the
known representative members of the S12 family, which were
subclustered according to their biochemical activity (-lacta-
mases, peptidases, esterases, and amidases). The second har-
bored the FmtA-like proteins (n 	 17) of the Staphylococcus
species (25) that were phylogenetically closer to ClbP than the
other members of the S12 family and that exhibited a predicted
topology identical to that of ClbP in contrast with the other S12
family members. The third branch exhibited the longest phylo-
genic distance, which clearly defined a subgroup containing
ClbP andmost closely related proteins (n	 60). These proteins,
designated ClbP-like, harbored a predicted topology identical
to that of ClbP. Some (n 	 14), such as ZmaM, possessed in
addition a putative half-size ABC-type exporter domain in the
C terminus. Except ClbP and its closest homolog (ClbP-like of
H. chejuensis) produced by different -proteobacteria, all of the
other ClbP-like were identified in taxons of the Firmicute phy-
lum (Bacillus andClostridium geni), which is themain bacterial
source of PK, NRP, and hybrid PK-NRP compounds with the
Actinobacteria phylum (38).
ClbP-like Proteins Display Functional Promiscuity—No
clues for the presence of megasynthase catalytic unit-encod-
ing genes were revealed in the vicinity of any fmtA-like and
17 clbP-like genes. In contrast, putative NRPS- and PKS-en-
coding genes were observed in the vicinity of 18 clbP-like genes
Structure and Functionality of ClbP Peptidase
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(supplemental Fig. 4). Moreover, putative NRPS-encoding
genes were present in all of these genomic islands unlike PKS-
encoding genes, suggesting that the cognate products contain
peptide moiety that may be related to the peptidase activity of
ClbP-like proteins. To test whether these enzymes are func-
tionally equivalent, we analyzed the ability of six representative
ClbP-like proteins (originating from different phyla, different
geni, and encoded by genes inserted or not in NRP biosynthesis
clusters) and one FmtA-like to xeno-complement the cyto-
pathic activity of the pks-positive E. coliclbP isogenic mutant.
Megalocytosis, G2/M cell cycle arrest, and histoneH2AX phos-
phorylation were restored by all ClbP-like proteins, whose gene
is located in a NRPS-encoding genomic island (n	 4) or is not
(n 	 2) (Fig. 3). In contrast, the FmtA-like protein did not
restore cytopathic activity despite its full expression (Fig. 3).
The efficient xeno-complementations thus support the func-
tional promiscuity of ClbP-like proteins. Moreover, these
results are evidence of substrate tolerance of NRP-associated
peptidases and confirm data obtained in experiments that have
investigated residues of the ClbP catalytic pocket potentially
involved in substrate binding.
DISCUSSION
The aim of this study was to identify the structure and func-
tion of the ClbP protein, which is essential to the genotoxic
activity of the pks island. The crystal structure of the ClbP enzy-
matic domain together with mutagenesis experiments and bio-
chemical assays revealed the same / fold observed in the
members of the MEROPS S12 family and a serine-reactive
active site conferring NRP-binding and peptidase activities
necessary to colibactin bioactivity. ClbP presented an unusually
wide and deep catalytic groove and an active site with original
structural features. We extended investigations to ClbP-like
proteins, which are the closest related proteins of ClbP, and are
clustered on a distinct phylogenetic branch in theMEROPSS12
enzyme family. ClbP and some ClbP-like-encoding genes
belong toNRPS-encoding gene clusters. TheClbP-like proteins
displayed functional promiscuity and shared a particular cellu-
lar localization and topology according to in silico analyses,
namely a large N-terminal extracytoplasmic peptidase domain
anchored to the inner membrane by three C-terminal trans-
membrane helices. Hence, ClbP and the closest related ClbP-
like proteins forma functional peptidase subgroup of S12 serine
enzymes, which is probably involved in NRP or PK-NRP bio-
synthesis. We propose to designate this subgroup the “NRP-
associated peptidases.”
Bioinformatics and biochemical analyses of the ZmAbiosyn-
thesis enzymes performed by Kevany et al. (37) suggest that the
compound is initially biosynthesized as part of a large metabo-
FIGURE 3. Functional promiscuity displayedbyClbP-like proteins.A, phe-
notypic analysis of pks island activity in E. coli strain DH10B/pBACpksclbP
complemented with empty vector, ClbP WT, four ClbP-like proteins geneti-
cally linked to NRPS gene clusters from H. chejuensis (Hche), B. weihenstepha-
nensis (Bwei), C. cellulolyticum (Ccel), and B. cereus (ZmaM), two ClbP-like pro-
teins genetically unlinked toNRPS gene clusters from B. mycoides (Bmyc), and
B. pseudomycoides (Bpse), or one FmtA-like protein from S. aureus.50%con-
fluent HeLa cells were infected 4 hwith 100 E. coli per cell. Left panels, the cell
morphology was observed following Giemsa staining at 72 h after infection
(bars, 50m).Middle panels, histone H2AX Ser-139 phosphorylation (H2AX)
indicative of DNAdouble-strand breakswas assayed by confocal immunoflu-
orescence at 20 h after infection. DNA and H2AX are pseudocolored in blue
and green, respectively (bars, 50 m). Right panels, G2 cell cycle arrest follow-
ing DNA damage was assayed by flow cytometry 48 h after infection. B, anti-
RGS6His Western blot analysis of the expression of RGS6His-tagged ClbP
wild-type protein, ClbP-like proteins, and FmtA-like protein in E. coli
DH10
/pBACpksclbP.
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lite that is processed by a peptidase, resulting in the formation
of ZmA. The only candidate enzyme encoded by the ZmA bio-
synthesis gene cluster to catalyze such a peptidase activity is
ZmaM, a ClbP-like protein. This observation and our results
suggest that NRP-associated peptidases can process NRP or
PK-NRP compounds. ClbP encoded by the pks island and the
other NRP-associated peptidases may process a procolibactin
and other NRP compounds into biologically active molecules
by cleaving a nonribosomal peptide bond. The ClbP-like pepti-
dase domain of ZmaM had been suggested to cleave a “pre-
ZmA”metabolite between the D-Asn and D-Ser, releasing ZmA
and a fatty acyl D-Asn (37). Interestingly, in silico analysis of
NRPS substrate specificity showed that all gene clusters pro-
ducing NRP-associated peptidases encode NRPS able to insert
the close related residues Asn and/or Gln into putative NRP
compounds, suggesting that these residues may be involved in
substrate recognition by NRP-associated peptidases. Of note,
ClbP-like proteins were the only proteins encoded by these
islands that harbored a predicted translocation signal sequence
and a predicted periplasmic catalytic domain, in contrast to
other enzymes involved in biosynthesis of PK, NRP, and mixed
compounds that are cytoplasmic proteins. Accordingly, NRP-
associated peptidases may act outside of the cytoplasm.
Several NRP-associated peptidases harbor in the C terminus
a typical half-size ABC exporter domain such as ZmaM (sup-
plemental Figs. 3 and 4). These ABC export systems are
involved in the extrusion of noxious substances and the export
of extracellular toxins (39). It has already been suggested that
these ABC exporters transport NRP compounds (39). ClbP and
otherNRP-associated peptidases did not harbor such an export
domain, but their cognate gene clusters encode a Multidrug
and Toxic Compound Extrusion transporter (such as ClbM in
the pks island) or other efflux pumps. After the translocation of
an inactive NRP compound from cytoplasm to periplasm via
efflux pumps, the periplasmic location of the NRP-associated
peptidase domain may allow the maturation of the fully active
toxin away from a potential cytoplasmic target of its producer
cell. NRP-associated peptidases and efflux pumps can be seen
therefore as a two-component resistance mechanism against
the possible toxic activity generated by the cognate NRPS-en-
coding gene cluster.
NRP-associated peptidases genetically linked to NRPS gene
clusters display a functional promiscuity with those genetically
unlinked to NRPS gene clusters. These latter peptidases may
also participate in the synthesis of a bioactive NRP compound
because we found one to three putative NRP biosynthetic clus-
ters in 15 of 16 genomes possessing aNRP-associated peptidase
genetically unlinked to a NRPS gene cluster. It has already been
suggested that enzymes required for NRP and PK biosynthesis
such as phosphopantetheinyl transferases are encoded in a dis-
tinct region of the main biosynthetic gene cluster in bacterial
genomes (40).
In conclusion, ClbP is a prototype of a new subfamily of
extracytoplasmic serine-reactive peptidases probably acting as
maturating enzymes for NRP compounds. The essential role of
ClbP in the production of the biological effectmake this protein
a key target for the control of the bioactivity of the PK-NRP-
producing pks gene cluster, which may affect commensalism
and/or pathogenicity and constitute a predisposing factor for
the development of colorectal cancer (7). The engineering of
NRP compounds should take into account these new catalytic
units, which could be interesting tools for modifying the struc-
tures and bioactivity of NRP and PK-NRP compounds and be a
target for identifying bioactive molecules.
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